$980.63 Million in Sales Expected for Alexion Pharmaceuticals, Inc. (ALXN) This Quarter
Wall Street analysts expect Alexion Pharmaceuticals, Inc. to announce $980.63 million in sales for the current quarter, Zacks reports. Nine analysts have provided estimates for Alexion Pharmaceuticals' earnings.
from Biotech News
0 Comments